At 12 months, a diagnosis of IgE-mediated egg allergy was given to a lower (but not significant) proportion of infants in the study group (33%) compared to the control group (51%; relative risk, 0.65; 95% CI, 0.38–1.11; p = 0.11). This evidence concerns the gene IGHE and egg allergy.